Starpharma Holdings Limited ASX:SPL, OTCQX:SPHRY is a global biopharmaceutical company based in Australia with established commercial partnerships and products launched, or nearing launch, within the pharmaceutical and sexual health sectors. Starpharma has developed a diverse portfolio of compelling products based on an underlying technology built around dendrimers. Starpharma s most advanced products are based on VivaGel SPL , astodrimer sodium , a proprietary dendrimer which has antimicrobial properties. VivaGel has been developed as two discrete products for bacterial vaginosis BV , firstly for the treatment of BV, and secondly, for the prevention of recurrent BV. These breakthrough products target areas of significant unmet medical need in high value markets. The VivaGel range includes the world s first and only antiviral condom licensed to several partners . Starpharma revolutionary DEP technology is being used to improve pharmaceuticals, to reduce toxicities and enhance their performance. There are numerous internal and partnered programs underway to develop DEP versions of existing drugs, particularly in the area of anti cancer. DEP partnerships include multiple programs with AstraZeneca and other world leading pharmaceutical companies. Starpharma has an IP portfolio of patents. The Starpharma HQ and research facilities are located in Melbourne Australia.
Quote | Starpharma Hldgs S/Adr (OTCMKTS:SPHRY)
Last: | $0.90 |
---|---|
Change Percent: | 0.0% |
Open: | $0.9 |
Close: | $0.90 |
High: | $0.9 |
Low: | $0.9 |
Volume: | 1,000 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Starpharma Hldgs S/Adr (OTCMKTS:SPHRY)
Uni Charm Corporation ADR (UNICY) is expected to report for Q2 2023 Clarus Therapeutics Hldgs (CRXTQ) is expected to report for quarter end 2023-06-30 Bed Bath & Beyond Inc. (BBBYQ) is expected to report for Q2 2024 CalAmp Corp. (CAMP) is expected to report $-0.04 for Q2 2024 ...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...
Message Board Posts | Starpharma Hldgs S/Adr (OTCMKTS:SPHRY)
Subject | By | Source | When |
---|---|---|---|
NEWS AGAIN and should soon reach new highs | PEACHMAN | investorshub | 06/12/2021 12:39:59 AM |
$NOW Sphry hitting 18..Up and AWAY Again | PEACHMAN | investorshub | 02/12/2021 7:20:29 PM |
now hitting 16 up up and away | PEACHMAN | investorshub | 02/10/2021 7:14:31 PM |
KABOOM $SPHRY over 14 now | PEACHMAN | investorshub | 02/06/2021 12:31:59 AM |
$SPHRY 12.62 and rising | PEACHMAN | investorshub | 12/29/2020 5:02:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Starpharma Hldgs S/Adr Company Name:
SPHRY Stock Symbol:
OTCMKTS Market:
Uni Charm Corporation ADR (UNICY) is expected to report for Q2 2023 Clarus Therapeutics Hldgs (CRXTQ) is expected to report for quarter end 2023-06-30 Bed Bath & Beyond Inc. (BBBYQ) is expected to report for Q2 2024 CalAmp Corp. (CAMP) is expected to report $-0.04 for Q2 2024 ...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...
Verbund AG ADR (OEZVY) is expected to report for Q2 2023 Adtran Networks SE (ADVOF) is expected to report for Q2 2023 OMV AG (OMVJF) is expected to report $1.66 for Q2 2023 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 Minim Inc (MINM) is expected to r...